Literature DB >> 22490318

Increased levels of tetra-antennary N-linked glycan but not core fucosylation are associated with hepatocellular carcinoma tissue.

Anand Mehta1, Pamela Norton, Hongyan Liang, Mary Ann Comunale, Mengjun Wang, Lucy Rodemich-Betesh, Alex Koszycki, Katsuhisa Noda, Eiji Miyoshi, Timothy Block.   

Abstract

BACKGROUND: Alterations in glycosylation have long been associated with the development of cancer. In the case of primary hepatocellular carcinoma (HCC), one alteration that has often been associated is increased amounts of fucose attached to the N-glycans of serum proteins secreted by the liver.
METHODS: In an effort to determine the origin of this increased fucosylation, we have conducted N-linked glycan analysis of HCC tissue, the surrounding nontumor tissue, and compared this to tissue from a nondiseased adult liver.
RESULTS: Surprisingly, no difference in the level of fucosylation was observed from the three donor groups, suggesting that the increased levels of fucosylation observed in serum of those with HCC is not the result of increased synthesis of fucosylated proteins in the cancer tissue. On the other hand, increased levels of a tetra-antennary glycan were observed in the HCC tissue as compared with the surrounding tissue or to the nondiseased livers.
CONCLUSIONS: This represents, to our knowledge, one of the first reports associating increased levels of branching with the development of HCC. IMPACT: The identification of increased levels of tetra-antennary glycan on liver tumor tissue, as opposed to adjacent or nondiseased tissue may lead to improved detection of HCC.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22490318      PMCID: PMC3380809          DOI: 10.1158/1055-9965.EPI-11-1183

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  43 in total

1.  Elevated expression of UDP-N-acetylglucosamine: alphamannoside beta1,6 N-acetylglucosaminyltransferase is an early event in hepatocarcinogenesis.

Authors:  Y Ito; E Miyoshi; M Sakon; T Takeda; K Noda; M Tsujimoto; S Ito; H Honda; F Takemura; K Wakasa; M Monden; N Matsuura; N Taniguchi
Journal:  Int J Cancer       Date:  2001-03-01       Impact factor: 7.396

2.  Chronic hepatitis B.

Authors:  A S Lok; B J McMahon
Journal:  Hepatology       Date:  2001-12       Impact factor: 17.425

Review 3.  The alpha1-6-fucosyltransferase gene and its biological significance.

Authors:  E Miyoshi; K Noda; Y Yamaguchi; S Inoue; Y Ikeda; W Wang; J H Ko; N Uozumi; W Li; N Taniguchi
Journal:  Biochim Biophys Acta       Date:  1999-12-06

Review 4.  Glycoprotein glycosylation and cancer progression.

Authors:  J W Dennis; M Granovsky; C E Warren
Journal:  Biochim Biophys Acta       Date:  1999-12-06

5.  Trends in survival of patients with hepatocellular carcinoma between 1977 and 1996 in the United States.

Authors:  H B El-Serag; A C Mason; C Key
Journal:  Hepatology       Date:  2001-01       Impact factor: 17.425

6.  An analytical and structural database provides a strategy for sequencing O-glycans from microgram quantities of glycoproteins.

Authors:  Louise Royle; Taj S Mattu; Edmund Hart; James I Langridge; Anthony H Merry; Neil Murphy; David J Harvey; Raymond A Dwek; Pauline M Rudd
Journal:  Anal Biochem       Date:  2002-05-01       Impact factor: 3.365

7.  Risk factors for hepatocellular carcinoma in patients with cirrhosis.

Authors:  Steedman A Sarbah; Terry Gramlich; Abraham Younoszai; Pat Osmack; Marlene Goormastic; Leonard Grosso; James N Cooper; Adrian Di Bisceglie; Russell Seneca; Zobair M Younossi
Journal:  Dig Dis Sci       Date:  2004-05       Impact factor: 3.199

8.  Relationship between elevated FX expression and increased production of GDP-L-fucose, a common donor substrate for fucosylation in human hepatocellular carcinoma and hepatoma cell lines.

Authors:  Katsuhisa Noda; Eiji Miyoshi; Jianguo Gu; Cong-Xiao Gao; Susumu Nakahara; Takatoshi Kitada; Koichi Honke; Kunio Suzuki; Harumasa Yoshihara; Kiyoshi Yoshikawa; Kiyoshi Kawano; Michela Tonetti; Akinori Kasahara; Masatsugu Hori; Norio Hayashi; Naoyuki Taniguchi
Journal:  Cancer Res       Date:  2003-10-01       Impact factor: 12.701

Review 9.  Molecular viral oncology of hepatocellular carcinoma.

Authors:  Timothy M Block; Anand S Mehta; Claus J Fimmel; Robert Jordan
Journal:  Oncogene       Date:  2003-08-11       Impact factor: 9.867

10.  The enzymatic basis for the conversion of nonfucosylated to fucosylated alpha-fetoprotein by acyclic retinoid treatment in human hepatoma cells: activation of alpha1-6 fucosyltransferase.

Authors:  K Noda; E Miyoshi; T Kitada; S Nakahara; C-X Gao; K Honke; Y Shiratori; H Moriwaki; Y Sasaki; A Kasahara; M Hori; N Hayashi; N Taniguchi
Journal:  Tumour Biol       Date:  2002 Jul-Aug
View more
  31 in total

Review 1.  Glycosylation and liver cancer.

Authors:  Anand Mehta; Harmin Herrera; Timothy Block
Journal:  Adv Cancer Res       Date:  2015-02-07       Impact factor: 6.242

2.  Insights into glycan biosynthesis in chemically-induced hepatocellular carcinoma in rats: A glycomic analysis.

Authors:  Amr Amin; Asma Bashir; Nazar Zaki; Diane McCarthy; Sanjida Ahmed; Mohamed Lotfy
Journal:  World J Gastroenterol       Date:  2015-05-28       Impact factor: 5.742

Review 3.  Glycoprotein disease markers and single protein-omics.

Authors:  Kevin Chandler; Radoslav Goldman
Journal:  Mol Cell Proteomics       Date:  2013-02-11       Impact factor: 5.911

4.  Site-specific analysis of changes in the glycosylation of proteins in liver cirrhosis using data-independent workflow with soft fragmentation.

Authors:  Miloslav Sanda; Lihua Zhang; Nathan J Edwards; Radoslav Goldman
Journal:  Anal Bioanal Chem       Date:  2016-11-07       Impact factor: 4.142

5.  Total serum glycan analysis is superior to lectin-FLISA for the early detection of hepatocellular carcinoma.

Authors:  Mary Ann Comunale; Mengjun Wang; Nikhil Anbarasan; Lucy Betesh; Aykan Karabudak; Ethan Moritz; Karthik Devarajan; Jorge Marrero; Timothy M Block; Anand Mehta
Journal:  Proteomics Clin Appl       Date:  2013-09-13       Impact factor: 3.494

6.  Quantitative Analysis of Sex-Hormone-Binding Globulin Glycosylation in Liver Diseases by Liquid Chromatography-Mass Spectrometry Parallel Reaction Monitoring.

Authors:  Wei Yuan; Julius Benicky; Renhuizi Wei; Radoslav Goldman; Miloslav Sanda
Journal:  J Proteome Res       Date:  2018-07-16       Impact factor: 4.466

7.  Site-specific glycoforms of haptoglobin in liver cirrhosis and hepatocellular carcinoma.

Authors:  Petr Pompach; Zuzana Brnakova; Miloslav Sanda; Jing Wu; Nathan Edwards; Radoslav Goldman
Journal:  Mol Cell Proteomics       Date:  2013-02-06       Impact factor: 5.911

8.  Differential N-Glycosylation Patterns in Lung Adenocarcinoma Tissue.

Authors:  L Renee Ruhaak; Sandra L Taylor; Carol Stroble; Uyen Thao Nguyen; Evan A Parker; Ting Song; Carlito B Lebrilla; William N Rom; Harvey Pass; Kyoungmi Kim; Karen Kelly; Suzanne Miyamoto
Journal:  J Proteome Res       Date:  2015-09-30       Impact factor: 4.466

9.  Development and application of a novel recombinant Aleuria aurantia lectin with enhanced core fucose binding for identification of glycoprotein biomarkers of hepatocellular carcinoma.

Authors:  Pamela Norton; Mary Ann Comunale; Harmin Herrera; Mengjun Wang; Josef Houser; Michaela Wimmerova; Patrick R Romano; Anand Mehta
Journal:  Proteomics       Date:  2016-11-28       Impact factor: 3.984

Review 10.  Epigenetic regulation of glycosylation and the impact on chemo-resistance in breast and ovarian cancer.

Authors:  Gordon Greville; Amanda McCann; Pauline M Rudd; Radka Saldova
Journal:  Epigenetics       Date:  2016-09-30       Impact factor: 4.528

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.